Aura Biosciences Shares Rise After JMP Securities Initiation
1:22PM ET 7/19/2022 MT NewswiresAura Biosciences (AURA) shares rose about 5% in Tuesday afternoon trading after JMP Securities started the stock at market outperform and set the price...
Quotes Snapshot > AURA
Aura Biosciences Inc AURA:NASDAQ
Last Price$14.86NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/23/22
NASDAQ 15-minute delayed Bid/Ask Quotes
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$14.36 (1)
Ask (Size)$16.37 (1)
Day Low / HighN/A - N/A
Volume50.0 K
Read more news Recent News
--JMP Securities Starts Aura Biosciences at Market Outperform With $26 Price Target
6:02AM ET 7/19/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Aura Biosciences Gets FDA Fast Track Designation for Bladder Cancer Drug
7:27AM ET 6/30/2022 MT NewswiresAura Biosciences (AURA) said Thursday the US Food and Drug Administration granted a Fast Track designation for its bladder cancer drug candidate belzupacap...
Aura Biosciences Reports Wider Loss for Q4
5:02PM ET 3/23/2022 MT NewswiresAura Biosciences (AURA) reported a Q4 net loss late Wednesday of $11.6 million, compared with a loss of $4.9 million a year earlier. Two analysts polled by...
View all Commentary and Analysis
Aura Biosciences (AURA) Investor Presentation - Slideshow
3:35PM ET 6/09/2022 Seeking AlphaAura Biosciences (AURA) Investor Presentation - Slideshow
1:38PM ET 3/08/2022 Seeking AlphaClearside's Safety Data In Wet AMD And Emphasis On SCS Microinjector Make It Great Speculative Play
8:05AM ET 12/22/2021 Seeking AlphaU.S. IPO Weekly Recap: Semiconductors And Energy Storage Lead A Spooky 14 IPO Week
11:43PM ET 10/30/2021 Seeking AlphaCompany Profile
Business Description
| Number of Employees | N/A |
| Recent SEC Filing | 08/11/2022 10-Q |
Company Highlights
| Price Open | $14.76 |
| Previous Close | $14.78 |
| 52 Week Range | $11.98 - 26.16 |
| Market Capitalization | $435.0 M |
| Shares Outstanding | 29.3 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 11/23/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$1.77 |
| Beta vs. S&P 500 | N/A |
| Revenue | N/A |
| Net Profit Margin | N/A |
| Return on Equity | -36.92% |
Analyst Ratings as of 07/18/2022
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |